Suppression of PP2A-B56α Drives EMT in EGFR Mutant Non-Small Cell Lung Cancer
Brittany N. Heil, Garima Baral, Claire M. Pfeffer, Mei B. Bahler, Sanika S. Gulavani, Emily G. Smith, Lauren E. Gartenhaus, Anna K. Darling, Sydney J. Clifford, Whitney R. Smith-Kinnaman, Kasi Hansen, Emma H. Doud, Gaganpreet K. Mall, Aaron N. Hata, Nicole L. Anderson, , Brittany L. Allen-Petersen
This study shows that suppressing PP2A-B56α promotes EMT in EGFR mutant NSCLC by reducing epithelial markers and increasing mesenchymal markers, leading to migratory and invasive phenotypes.
Oncogene · Apr 11, 2026Peer-reviewedCancer Biology